Reducing Delay of Carotid Endarterectomy in Acute Ischemic Stroke Patients

Witt, Agnes; Johnsen, Søren Paaske; Jensen, Leif Panduro; Hansen, Allan Kornmaaler; Hundborg, Heidi Holmager; Andersen, Grethe

doi:10.1161/strokeaha.111.678565

Cited by 23 publications

(11 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, the median time to surgery was only approaching the national guideline of 14 days in 2010 (16 days), and meeting the guideline in 2014 (8 days). This lag has also been demonstrated in other studies conducted internationally …”

Section: Discussionsupporting

confidence: 81%

Carotid endarterectomy: the change in practice over 11 years in a stroke centre

Tse

Kilkenny

Bladin

et al. 2017

ANZ Journal of Surgery

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 81%

Carotid endarterectomy: the change in practice over 11 years in a stroke centre

Tse

Kilkenny

Bladin

et al. 2017

ANZ Journal of Surgery

View full text Add to dashboard Cite

show abstract

“… 44 A Danish nationwide initiative was able to increase the percentage of CEA within the recommended timeframe from 13% in 2007 to 47% in 2010. 45 The evidence of the early procedure safeness is more robust for CEA than for CAS which has conflicting results in different studies. 46 - 48 …”

Section: Resultsmentioning

confidence: 99%

Risk-Benefit Assessment of Carotid Revascularization

Oliveira

Vieira

Guimarães

et al. 2018

Arquivos Brasileiros De Cardiologia

View full text Add to dashboard Cite

Severe carotid atherosclerotic disease is responsible for 14% of all strokes, which result in a high rate of morbidity and mortality. In recent years, advances in clinical treatment of cardiovascular diseases have resulted in a significant decrease in mortality due to these causes.To review the main studies on carotid revascularization, evaluating the relationship between risks and benefits of this procedure.The data reviewed show that, for a net benefit, carotid intervention should only be performed in cases of a periprocedural risk of less than 6% in symptomatic patients. The medical therapy significantly reduced the revascularization net benefit ratio for stroke prevention in asymptomatic patients. Real life registries indicate that carotid stenting is associated with a greater periprocedural risk. The operator annual procedure volume and patient age has an important influence in the rate of stroke and death after carotid stenting. Symptomatic patients have a higher incidence of death and stroke after the procedure. Revascularization has the greatest benefit in the first weeks of the event.There is a discrepancy in the scientific literature about carotid revascularization and/or clinical treatment, both in primary and secondary prevention of patients with carotid artery injury. The identification of patients who will really benefit is a dynamic process subject to constant review.

show abstract

“…The impact of the Danish National Indicator Project, launched in 2008, has been investigated in a Danish nationwide survey which showed that from 2007 to 2010, the percentage of patients with stroke and ICA stenosis who underwent CEA within 2 weeks increased from 13% to 47% (Witt et al, 2013). In the years before this study, our vascular department (Rathenborg et al, 2008) and others (Noronen et al, 2012) reduced the time from referral to surgery by introducing an accelerated course of examinationsa so-called fast track.…”

Section: Discussionmentioning

confidence: 99%